about
Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogsRepurposing Clinical Molecule Ebselen to Combat Drug Resistant PathogensAntibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermediusAntibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse ModelIn Vitro Antibacterial Activity of Rhodanine Derivatives against Pathogenic Clinical IsolatesDual Targeting of Intracellular Pathogenic Bacteria with a Cleavable Conjugate of Kanamycin and an Antibacterial Cell-Penetrating Peptide.Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection.Brucella: a pathogen without classic virulence genes.Brucellosis: a re-emerging zoonosis.Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci.Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial InfectionsOverexpression of Brucella putative glycosyltransferase WbkA in B. abortus RB51 leads to production of exopolysaccharide.Repurposing ebselen for treatment of multidrug-resistant staphylococcal infectionsRepurposing celecoxib as a topical antimicrobial agent.Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens.Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells.Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection.Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agentRepurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 PathwayIn Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.Discovery and characterization of aryl isonitriles as a new class of compounds versus methicillin- and vancomycin-resistant Staphylococcus aureusImpact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens.Repurposing auranofin for the treatment of cutaneous staphylococcal infections.Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureusTargeting listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids.Peptide nucleic acids inhibit growth of Brucella suis in pure culture and in infected murine macrophages.Comparative virulence studies and transcriptome analysis of Staphylococcus aureus strains isolated from animals.Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase.Label-Free Detection and Discrimination of Bacterial Pathogens Based on Hemin Recognition.Nanomedicine for intracellular therapy.Phenotypic profiling of antibiotic response signatures in Escherichia coli using Raman spectroscopy.Drug repurposing for the treatment of staphylococcal infections.Antimicrobial peptides and peptidomimetics - potent therapeutic allies for staphylococcal infections.Virulence and transcriptome profile of multidrug-resistant Escherichia coli from chicken.Establishment of a gene expression system in Ochrobactrum anthropiTargeting intracellular bacteria with an extended cationic amphiphilic polyproline helix.Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.Targeting intracellular pathogenic bacteria with unnatural proline-rich peptides: coupling antibacterial activity with macrophage penetration.Effect of entF deletion on iron acquisition and erythritol metabolism by Brucella abortus 2308.
P50
Q28542965-9B421E53-ACAD-4266-8EBD-D7AC33C76B24Q28546863-6B2DB6C0-7BEE-486E-A5D0-AA66254C9BEFQ28548455-274586FB-301B-4F68-96BC-98D80AB7431BQ28550691-59360893-37B5-48E3-9E9A-1925C9E3B7F0Q28554549-94D9408F-47A7-4FB5-8A88-622D030AA0BCQ33828350-E2169EB0-FE61-42C7-9EF2-7F318F751693Q34394175-7B0CE296-FE29-44BC-99A2-DB1E302D8DB7Q34742721-4BBDB913-C4E3-4785-B6CF-FD2B9753190AQ34992396-E817C7D4-4F6C-4DDC-BC29-F970F8DEE21FQ35577377-3D34DCC9-B3EA-4815-956E-65A2562643F8Q35599090-008D2139-DD7C-4810-9E14-6A791FFA69D8Q35626649-B63DD595-55E9-4761-AFB8-FEE535DB0AE6Q35773649-53682484-8647-4280-8A2A-C806AAB9BBF5Q35783692-E32CC8B1-5DDA-4DFD-9A62-4487FC3A04C6Q35895183-5C1BEA92-D646-4889-8622-29675E17A138Q35943844-0B023FA5-91D8-473F-B3C3-D95C88E223E3Q36155799-EE03D63B-4EC3-4FF3-BA6F-00D978324D45Q36212803-CD2118DD-AD14-4474-8D3B-79B6D165C052Q36265781-E9A89802-B500-4753-B148-F658E8F69D02Q36266986-119BFD89-37BF-4A9F-B3BB-A07718B985AAQ36278065-28CE4BD8-61D1-49DF-A5A7-FB60B84B9B54Q36392641-205EE2D7-E861-481F-A94B-6FD44C971FD2Q36565579-E6E9F406-4559-4D38-88C5-C9A5113CFF7BQ36689702-305AC618-DE68-478A-B67D-0E84DAEF30B1Q37089144-D4B72637-D893-4E9F-80FE-BBD14FC3688FQ37139639-99C018D0-37D4-4F07-B9FA-65A82995A855Q37327293-3C38D5E7-4790-4A03-8697-0606624FDCF4Q37339803-33CCC934-54EA-4C58-A0E5-5AB6AD5503DDQ37557968-9E982356-E447-4C8B-9276-887FE7625D4BQ37643778-5A9B4A56-B8C9-46C5-88DE-182DD71DCA23Q37999384-F7E59556-5969-48B9-9868-D0871C6EE8F6Q38324541-0ADB643C-5395-455D-94BC-1ECD34ABF810Q38373639-E2CA373E-7E62-4A6C-B91B-8D4E13CB8883Q38373648-FCFF75D5-80BE-48F5-93EB-54CF19460C60Q38615315-451988CD-9D51-44C7-8AE0-DCCDECB11161Q38668152-D7A31408-3731-4E3D-8464-AD560D31227EQ38880898-3D2FCEE3-E379-4E77-AF40-44082511F728Q38998331-B32645C8-ECE2-41E5-8B1F-CE0BC6CA3F6AQ39107880-D0BEED71-72A7-4158-9FE4-956AD88A2DC6Q39612553-2E4BF57C-9AF4-4E7C-BA7D-2489CB52BDD3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mohamed N. Seleem
@ast
Mohamed N. Seleem
@en
Mohamed N. Seleem
@es
Mohamed N. Seleem
@nl
Mohamed N. Seleem
@sl
type
label
Mohamed N. Seleem
@ast
Mohamed N. Seleem
@en
Mohamed N. Seleem
@es
Mohamed N. Seleem
@nl
Mohamed N. Seleem
@sl
prefLabel
Mohamed N. Seleem
@ast
Mohamed N. Seleem
@en
Mohamed N. Seleem
@es
Mohamed N. Seleem
@nl
Mohamed N. Seleem
@sl
P106
P1153
6701651727
P21
P31
P496
0000-0003-0939-0458